Galactose-1-phosphate uridylyltransferase (GALT)

The protein contains 379 amino acids for an estimated molecular weight of 43363 Da.

 

Plays an important role in galactose metabolism. (updated: Oct. 10, 2018)

Protein identification was indicated in the following studies:

  1. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.
  2. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

Interpro domains
Total structural coverage: 92%
Model score: 0
No model available.

(right-click above to access to more options from the contextual menu)

VariantDescription
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
dbSNP:rs1800461
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1
GALAC1

The reference OMIM entry for this protein is 230400

Galactosemia
Galactose-1-phosphate uridylyltransferase deficiency
Galt deficiency
Galactosemia, classic galactosemia, duarte variant

A number sign (#) is used with this entry because classic galactosemia is caused by homozygous or compound heterozygous mutation in the galactose-1-phosphate uridylyltransferase gene (GALT; 606999) on chromosome 9p13.

DESCRIPTION

Classic galactosemia is an autosomal recessive disorder of galactose metabolism. Most patients present in the neonatal period, after ingestion of galactose, with jaundice, hepatosplenomegaly, hepatocellular insufficiency, food intolerance, hypoglycemia, renal tubular dysfunction, muscle hypotonia, sepsis, and cataract. Long-term complications include mental retardation, verbal dyspraxia, motor abnormalities, and hypergonadotropic hypogonadism (summary by Bosch, 2006).

CLINICAL FEATURES

The first detailed description of galactosemia was given by Goppert (1917). The proband (A.G.) presented with large liver, icterus, failure to thrive, and urinary excretion of albumen and sugar. After exclusion of galactose from the diet, these signs and symptoms normalized. He was mentally retarded (developmental quotient of 14 months at 36 months of age). He tolerated sucrose, maltose, glucose, and fructose at doses of 2 g/kg, but after lactose or galactose there was dose-dependent galactosuria. His oldest brother had suffered from icterus and liver enlargement a few days after birth and had had a life-threatening bleed after ritual circumcision. He died after 6 weeks. At autopsy, a huge liver tumor was present (attributed to syphilis, although subsequent Wassermann reactions were negative), and the cause of his death was attributed to nephritis. His third sib, born somewhat prematurely, became icteric, and died after 4 weeks. Goppert (1917) concluded that the patient was suffering from a familial liver disorder and that in such cases lactose must be replaced by another sugar, e.g., sucrose or maltose. Another early detailed description of galactosemia was given by Mason and Turner (1935). Segal (1989) presented a picture of a 30-year-old man diagnosed in infancy by Mason and Turner (1935). Failure to thrive is the most common initial clinical symptom of galactosemia. Vomiting or diarrhea usually begins within a few days of milk ingestion. Jaundice of intrinsic liver disease may be accentuated by the severe hemolysis occurring in some patients. Cataracts have been observed within a few days of birth. These may be found only on slit-lamp examination and missed with an ophthalmoscope, since they consist of punctate lesions in the fetal lens nucleus (Holton et al., 2001). There appears to be a high frequency of neonatal death due to E. coli sepsis, with a fulminant course (Levy et al., 1977). Litchfield and Wells (1978) suggested that this proneness to sepsis is due to inhibition of leukocyte bactericidal activity. Ruiz et al. (1999) concluded that coagulopathy may be present in galactosemia with little evidence of liver disease (Levy et al., 1996). They suggested, furthermore, that the association of jaundice and hemorrhagic diathesis in the first 2 weeks of life is a clinical presentation in which galactosemia must be considered. - Pregnancy Ovarian failure in many affected girls (Kaufman et al., 1979) may indicate in utero damage from galactosemia. Pregnancy is rare in women with galactosemia because of the high frequency of hypergonadotropic hypogonadism with ovarian atrophy. Harley et al. (1974) found low levels (presumably indicative of the heterozygous state) of galactose-1-phosphate uridylyltransferas ... More on the omim web site

Subscribe to this protein entry history

Oct. 19, 2018: Protein entry updated
Automatic update: OMIM entry 230400 was added.

Oct. 19, 2018: Additional information
Initial protein addition to the database. This entry was referenced in Bryk and co-workers. (2017).